2013年 第7卷 第3期
《医学前沿（英文）》 >> 2013年 第7卷 第3期 doi: 10.1007/s11684-013-0265-3
Identification of cancer gene fusions based on advanced analysis of the human genome or transcriptome
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
下一篇 上一篇
摘要
Many gene fusions have been recognized as important diagnostic and/or prognostic markers in human malignancies. In recent years, novel gene fusions have been identified in cases without prior knowledge of the genetic background. Accompanied by a powerful computational data analysis method, new genome-wide screening approaches were used to detect cryptic genomic aberrations. This review focused on advanced genome-wide screening approaches in fusion gene identification, such as microarray-based approaches, next-generation sequencing, and NanoString nCounter gene expression system. The fundamental rationale and strategy for fusion gene identification using each biotech platform are also discussed.
京公网安备 11010502051620号
